Biocon Limited
BIOCON
주식 순위
#3387
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
주가
$3.75
마지막 동기화: 2026-10-19
시가총액
$5.13B
변동 (1일)
-2.30%
변동 (1년)
-9.49%
국가
IN
거래 Biocon Limited (BIOCON)
카테고리
Healthcare
Biocon Limited (BIOCON)의 P/S 비율
October 2026 기준 P/S 비율 TTM: 2.80
Biocon Limited의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 2.80입니다. 2024년 말 기준 P/S 비율은 2.19였습니다.
Biocon Limited의 P/S 비율 기록 (2004 ~ 2026)
매년 말 P/S 비율
| 연도 | P/S 비율 | 변화 |
|---|---|---|
| 2026 (TTM) | 2.80 | 5.35% |
| 2025 | 2.66 | 21.75% |
| 2024 | 2.19 | -0.79% |
| 2023 | 2.20 | -54.89% |
| 2022 | 4.88 | -28.13% |
| 2021 | 6.80 | 33.65% |
| 2020 | 5.08 | -23.50% |
| 2019 | 6.65 | -22.37% |
| 2018 | 8.56 | 49.90% |
| 2017 | 5.71 | 101.52% |
| 2016 | 2.83 | -6.69% |
| 2015 | 3.04 | 12.72% |
| 2014 | 2.70 | 18.90% |
| 2013 | 2.27 | -0.79% |
| 2012 | 2.28 | -22.10% |
| 2011 | 2.93 | 7.96% |
| 2010 | 2.72 | 34.93% |
| 2009 | 2.01 | -59.64% |
| 2008 | 4.99 | -12.65% |
| 2007 | 5.71 | -7.76% |
| 2006 | 6.19 | 3.79% |
| 2005 | 5.97 | -26.97% |
| 2004 | 8.17 | 0.00% |
유사 기업 또는 경쟁사의 P/S 비율
| 회사 | P/S 비율 | P/S 비율 차이 | 국가 |
|---|---|---|---|
| 10.02 | 257.64% |
US
|
|
| 40.55 | 1,347.05% |
US
|
|
| 3.96 | 41.35% |
AU
|
|
| - | - |
CH
|
|
| 10.15 | 262.07% |
NL
|
